Triflupromazine hydrochloride

CAS No. 1098-60-8

Triflupromazine hydrochloride( —— )

Catalog No. M10378 CAS No. 1098-60-8

Triflupromazine hydrochloride is an antipsychotic medication, which are Dopamine D1/D2 receptor antagonists.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 28 In Stock
200MG 47 In Stock
500MG 76 In Stock
1G 110 In Stock

Biological Information

  • Product Name
    Triflupromazine hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Triflupromazine hydrochloride is an antipsychotic medication, which are Dopamine D1/D2 receptor antagonists.
  • Description
    Triflupromazine hydrochloride is an antipsychotic medication, which are Dopamine D1/D2 receptor antagonists.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    5-HT Receptor
  • Recptor
    5-HT| mAChR| Dopamine
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    1098-60-8
  • Formula Weight
    388.88
  • Molecular Formula
    C18H20ClF3N2S
  • Purity
    >98% (HPLC)
  • Solubility
    Water: 0.0018 mg/mL
  • SMILES
    Cl.CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Snyder S, et al. Arch Gen Psychiatry. 1974 Jul;31(1):58-6
molnova catalog
related products
  • Pheniramine maleate

    Pheniramine Maleate is an antihistamine with anticholinergic properties used to treat allergic conditions such as hay fever or urticaria.

  • SHP099 hydrochloride

    SHP099 is a potent, selective, orally bioavailable, and efficacious SHP2 inhibitor.

  • 8-Hydroxy-DPAT hydro...

    8-Hydroxy-DPAT hydrobromide (8-OH-DPAT hydrobromide) is a potent and selective 5-HT1A agonist with a pIC50 of 8.19. 8-Hydroxy-DPAT hydrobromide has a selectivity of almost 1000 fold for a subtype of the 5-HT1 binding site.